Method of treatment of HIV-seropositive individuals with dietary whey proteins
Patent 5456924 Issued on October 10, 1995. Estimated Expiration Date: 
October 10, 2012. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
October 10, 2012. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesImmunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome HIV related peptides, immunogenic antigens, and use therefor as subunit vaccine for AIDS virus Synthetic vaccine against AIDS virus Apparatus for controlling and eliminating vapor emissions at a manicure work station Patent #: 5112373 InventorsAssigneeApplicationNo. 866756 filed on 04/10/1992US Classes:424/535, Milk or colostrum (e.g., butter, whey, etc.)426/72, PRODUCT WITH ADDED VITAMIN OR DERIVATIVE THEREOF FOR FORTIFICATION514/2, Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI514/21Produced by or extracted from animal tissueExaminersPrimary: Naff, David M.Assistant: Witz, Jean C. Attorney, Agent or FirmForeign Patent References
International ClassA61K 035/20AbstractUndenatured whey protein concentrate is administered to HIV-seropositive individuals to elevate their blood mononuclear cells, glutathione (GSH) level, body weight and sense of well being. In addition T-helper cells concentration and their T-helper cells/T-suppressor cells ratio are slightly elevated.Other References
| |
